Motor Neurone Disease Trial, Recruiting NCT07257302 Sponsor: National Center of Neurology and Psychiatry, Japan Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT07257302
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 20 years old or older
  • You have been diagnosed with ALS (also known as Lou Gehrig's disease) based on specific recognised medical criteria
  • You are not currently using a breathing support machine (such as a CPAP or BiPAP mask) and have not had a breathing tube surgically placed in your throat
  • You are able to take part in the study activities and sign a consent form yourself, or with help from a communication device

Who may not be able to join:

  • You have a long-term lung condition unrelated to ALS, such as COPD or scarring of the lungs
  • You have serious difficulties with memory, thinking, or communication that would prevent you from taking part in the study
  • You have a heart condition that is not well controlled, such as unstable chest pain, a recent heart attack, severe heart failure, a serious irregular heartbeat, a severely narrowed heart valve, or active heart infection
  • Your blood pressure is not well controlled
  • You currently have an illness with a fever or feel acutely unwell
  • You have recently had a blood clot in your lungs, a severe strain on the right side of your heart, or very high blood pressure in your lung arteries
  • You have serious problems with your liver or kidneys
  • The trial doctor feels that, for any other reason, joining the trial would not be appropriate for you (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Taiyo Kawaguchi, MD, National Center of Neurology and Psychiatry

Phone: +81-42-341-2712

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Center of Neurology and Psychiatry, Japan
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
31 March 2028

Where this trial is recruiting

🇯🇵 Japan

Primary endpoints

Overall survival (time to tracheostomy or death)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov